XK and influenza: The threat of antiviral resistance in future influenza outbreaks warrants further exploration of alternative therapeutic strategies, e.g., new classes of drugs used in combination therapy with NA inhibitors [22], [23] or alternative technologies for faster production of influenza vaccine [62].